SEMIGRAN MARC (Chief Medical Officer) sold 45K shares of MYOKARDIA, INC. on the open market
Open‑market sale worth $2.68M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/6/2018ACC: 0000899243-18-023935
Officer· Chief Medical Officer
Since Sep 2018
-45K
Net shares
Net seller
$2.68M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
45K acquired · 90K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+41.40K
Price / share
$15.95
Trade value
$660.33K
% of position
New position
9/4/2018
0.00→41.40K
Common Stock
Direct
Shares
−41.40K
Price / share
$59.49
Trade value
$2.46M
% of position
New position
9/4/2018
41.40K→0.00
Common Stock
Direct
Shares
+3.60K
Price / share
$15.95
Trade value
$57.42K
% of position
New position
9/5/2018
0.00→3.60K
Common Stock
Direct
Shares
−3.60K
Price / share
$60.00
Trade value
$216K
% of position
New position
9/5/2018
3.60K→0.00
Total
Net shares
+0.00
Net value
-$1.96M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/4/2018 | M · Option Exercise | +41.40K | $15.95 | $660.33K | New position | 0.00 | 41.40K |
| Common Stock Direct | 9/4/2018 | S · Sale | −41.40K | $59.49 | $2.46M | New position | 41.40K | 0.00 |
| Common Stock Direct | 9/5/2018 | M · Option Exercise | +3.60K | $15.95 | $57.42K | New position | 0.00 | 3.60K |
| Common Stock Direct | 9/5/2018 | S · Sale | −3.60K | $60.00 | $216K | New position | 3.60K | 0.00 |
| Total | +0.00 | -$1.96M | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
41.40K shares
Shares
−41.40K
Strike price
15.95
Held after
133.60K
Exercisable
—
9/4/2018
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.60K shares
Shares
−3.60K
Strike price
15.95
Held after
130K
Exercisable
—
9/5/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock41.40K shares | 9/4/2018 | M · Option Exercise | −41.40K | 15.95 | — | 133.60K |
| Stock Option (Right to Buy) Direct | Common Stock3.60K shares | 9/5/2018 | M · Option Exercise | −3.60K | 15.95 | — | 130K |